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Abstract
DNA methylation is a key epigenetic mark involved in both normal development and disease 
progression. Recent advances in high-throughput technologies have enabled genome-wide 
profiling of DNA methylation. However, DNA methylation profiling often employs different 
designs and platforms with varying resolution, which hinders joint analysis of methylation data 
from multiple platforms. In this study, we propose a penalized functional regression model to 
impute missing methylation data. By incorporating functional predictors, our model utilizes 
information from nonlocal probes to improve imputation quality. Here, we compared the 
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performance of our functional model to linear regression and the best single probe surrogate in 
real data and via simulations. Specifically, we applied different imputation approaches to an acute 
myeloid leukemia dataset consisting of 194 samples and our method showed higher imputation 
accuracy, manifested, for example, by a 94% relative increase in information content and up to 
86% more CpG sites passing post-imputation filtering. Our simulated association study further 
demonstrated that our method substantially improves the statistical power to identify trait-
associated methylation loci. These findings indicate that the penalized functional regression model 
is a convenient and valuable imputation tool for methylation data, and it can boost statistical power 
in downstream epigenome-wide association study (EWAS).
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Introduction
DNA methylation is an important epigenetic modification involved not only in normal 
development [Smith and Meissner, 2013], but also in risk and progression to many diseases 
[Bergman and Cedar, 2013]. It has been shown to play a key role in the regulation of gene 
transcription, X-inactivation, cellular differentiation, and other critical processes such as 
aging [Bird, 2002; Gonzalo, 2010]. Recently, the emergence of powerful technologies such 
as microarray-based DNA methylation studies [Bibikova et al., 2011] and whole-genome 
bisulfite sequencing [Harris et al., 2010] has enabled the profiling of DNA methylation 
levels at high resolution. Numerous studies employed these high-throughput approaches to 
characterize changes in DNA methylation patterns and their corresponding tissue- and 
disease-specific differentially methylated regions on a genome-wide scale [Berman et al., 
2012; Chen, Ning, Hong, & Wang, 2014; Horvath, 2013; Varley et al., 2013].
As new technologies emerge, researchers tend to replace older methylation profiling 
platforms with new ones. However, different platforms can target CpG sites at different 
locations and with varying resolutions, which hinders the joint analysis of data from multiple 
platforms. For instance, the Illumina HumanMethylation27 (HM27) and Human-
Methylation450 (HM450) BeadChip [Bibikova et al., 2011] are two common microarrays 
used by The Cancer Genome Atlas (TCGA) project. HM27 investigates 27,578 CpG sites 
predominantly located near CpG islands, while HM450 provides broader coverage with 
485,577 probes spanning 96% of CpG islands and 92% of CpG shores across a larger 
number of genes [Bibikova et al., 2011]. Several TCGA studies have used HM450 to 
generate methylation profile data for more recently collected samples while still using 
HM27 to measure DNA methylation in the older test subjects. These mixed profiles compel 
researchers to focus on those probes shared between the two platforms when using the data 
for downstream analysis, as reevaluating all samples using HM450 is not only expensive, but 
also time-consuming [Getz et al., 2013; Koboldt et al., 2012; The Cancer Genome Atlas 
Research Network, 2012, 2013].
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Imputation has been successfully employed in many genetic, genomic, and epigenomic 
contexts [Donner et al., 2012; Ernst and Kellis, 2015; Jewett et al., 2012; Li et al., 2009; 
Zhang et al., 2015]. For methylation profiling, multiple methods have been proposed to 
impute methylation levels across tissue types [Ma et al., 2014] or employing various 
genomic and epigenomic features, including DNA sequence context, genomic position, 
predicted DNA structure, GC content, and DNA regulatory elements [Bock et al., 2006; Das 
et al., 2006; Zhang et al., 2015]. However, most of these methods dichotomize methylation 
status. More importantly, no cross-platform imputation methods have been proposed for 
predicting methylation levels at unassayed CpG sites. On the other hand, for genotypes, 
imputation of untyped SNPs has become a standard procedure used both to resolve similar 
inconsistencies between genotyping arrays and to increase the resolution of genotype data 
collected in genome-wide association studies [Li et al., 2009]. Here, we propose the 
application of a similar concept to impute data in DNA methylation profiles from a subset of 
probes. Although DNA methylation does not exhibit as clear or strong a correlation structure 
as LD blocks among SNPs, we observe local correlation among neighboring probes similar 
as reported by others [Eckhardt et al., 2006; Zhang et al., 2015]. Importantly, we have found 
nonlocal correlations among probes falling into the same functional categories that have not 
been employed in the literature. Therefore, we adopt a penalized functional regression model 
[Goldsmith et al., 2011], which uses functional predictors to capture these nonlocal 
correlations. Our study demonstrates that this model can impute an HM27 dataset into an 
HM450 dataset effectively and accurately, and using these imputed values can improve the 
statistical power of downstream epigenome-wide association study (EWAS).
Materials and Methods
Data
We evaluated our imputation model using DNA methylation data from TCGA acute myeloid 
leukemia (AML) samples [Ley et al., 2013]. The dataset contains DNA methylation data of 
tumor tissues from 194 patients with AML and is one of the largest methylation datasets 
from the TCGA project. All samples were evaluated using both HM27 and HM450. We 
transformed the raw β values into M values, defined as M = log 2[β/(1 – β)], as the M values 
better follow a Gaussian distribution [The Cancer Genome Atlas Research Network, 2013]. 
Our goal is to impute the HM27 dataset into an HM450 dataset to get an expanded view of 
the epigenomic landscape. The dataset is publicly available at the TCGA data portal (https://
tcga-data.nci.nih.gov/tcga/).
Because imputation of sporadic missing data is not the focus of this work, we removed all 
probes with at least one missing values for the sake of convenience. However, these missing 
values can be imputed by applying similar methods developed for gene expression profiles 
[Bo, Dysvik, & Jonassen, 2004; Kim et al., 2005; Liew et al., 2011; Troyanskaya et al., 
2001] to generate data without missing values. Additionally, we removed 743 probes 
designed in HM27 but not in HM450. In total, the HM27 dataset consisted of 20,794 probes 
passing TCGA quality control (QC) criteria [Ley et al., 2013] and the HM450 dataset 
consisted of 393,152 QC+ probes. The latter set contained all 20,794 probes in HM27, 
leaving the remaining 373,358 as our potential imputation targets.
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When training and using our model, we required data from HM450 and HM27, respectively. 
However, we noted that as HM27 and HM450 employ different biochemical methods to 
measure methylation levels, platform-specific effects might negatively impact imputation 
performance. To alleviate this systematic effect, we fitted a LOESS (locally weighted 
scatter-plot smoothing) regression model [Cleveland, 1979] between two platforms, 
stratified by the number of CpGs in the probe (#CpG = 0, 1, 2, 3, 4, 5, 6, 7+), using 14 
randomly chosen samples and normalized the HM27 data against the HM450 data [The 
Cancer Genome Atlas Research Network, 2013].
Penalized Functional Regression Model
We employed the penalized functional regression model [Goldsmith et al., 2011] with minor 
modifications detailed below to quantify the relationship between DNA methylation from 
HM450 probes and the DNA methylation density function estimated from HM27 probes 
together with other covariates. Specifically, assume for each target HM450 probe, we have n 
observations and for each sample i = 1, 2, …, n, we have data [Yi, Xi(t), Zi], where Yi is the 
transformed DNA methylation level at the target HM450 probe, Xi(t) is the sample-specific 
density function of the DNA methylation level measured by HM27 probes, denoted as Ti, 
and Zi is a p-dimensional vector of covariates. We consider a functional linear regression 
model:
Here, α is the overall mean, β(t) is the functional coefficient that characterizes the effect of 
density function Xi(t) when Ti = t, γ is the regression coefficient vector for covariates, and εi 
~ N(0, σ2).
To improve imputation accuracy, we incorporated functional predictors Xi(t) into our model 
to capture information such as nonlinear relationships from nonlocal probes. Based on the 
assumption that probes with similar properties tend to show similar methylation profiles, we 
divided the probes into several property groups. Here, we divided the probes among five 
groups according to their relative location to a CpG island. The five groups are “CpG 
Island,” “North Shore,” “South Shore,” “North Shelf,” and “South Shelf” [Bibikova et al., 
2011]. Then, we estimated the DNA methylation function Xi(t) for a particular target probe 
with the DNA methylation data from HM27 probes in the same group as the target probe. 
Assume the target probe is in group g and there are q HM27 probes in the same group. The 
observed DNA methylation data are denoted as , where  is the DNA 
methylation value at jth HM27 probe in group g and j = 1, …, q. Instead of estimating Xi(t) 
by expanding into the principal component basis obtained from its covariance matrix 
[Goldsmith et al., 2011], we used the kernel density estimation to obtain Xi(t) with  so that 
it is specific to group g.
To perform the model fitting, the functional coefficient β(t) was expanded by a linear spline 
basis , where δk is the knot along the interval [0,1] and (t – 
δk)+ is an indicator function, taking a value of 1 if t > δk and 0 if t ≤ δk. We further defined a 
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spline basis vector φ(t) = {φ1(t), φ2(t), …, φKb (t)} = {1, t, (t – δ3)+, …, (t – δKb)+} and a 
coefficient vector b = (b1, …, bKb)′ so that we may induce smoothing by assuming 
b~N(0,D), where D is a penalty matrix corresponding to the particular spline basis ϕ(t).
Finally, we had . For ease of notation, 
we denoted JXϕ as the n×Kb matrix with the (i,k)th entry equal to  and Z as 
the n × p matrix with the ith row equal to Zi, where p is the number of covariates. The model 
can be written in matrix format as:
This is a mixed effect model with Kb random effects b and penalty matrix:
Typically, Kb = 30 is sufficient to avoid under-smoothing in most applications [Goldsmith et 
al., 2011]. Consistent with previous work [Fan et al., 2015a,2015b], choice of Kb has little 
impact on performance (Supplementary Fig. S2).
Selection of Local Covariates
We exploited linear correlation with neighboring probes by including methylation values of 
HM27 probes near the target HM450 probe as local covariates Z in our imputation model. 
For simplicity, we selected the five nearest upstream probes and the five nearest downstream 
probes to each target probe as these local covariates.
Quality Filter
Because most probes showed nearly constant methylation levels across samples, we found 
for many probes, the imputation model is formed without sufficient information. Thus, it 
tends to be underfitted and yields inaccurate imputation results. It is therefore desirable to 
have quality metrics for gauging the imputation quality. As such a quality metric, we 
proposed an under-dispersion measure defined as the ratio of the variance of fitted 
methylation values to its expected value (the variance of the true methylation values in the 
training set). If this ratio is below a certain threshold for a probe, it indicates an underfitted 
model for that probe, and we discard imputed values for the probe before subsequent 
analysis. A more stringent threshold can provide more accurate results, although at the cost 
of more probes discarded after imputation.
Imputation Quality Assessment
We assessed imputation quality using fivefold cross-validation. Within each split, the full 
dataset was randomly divided into a training set consisting of 80% of the samples and a 
testing set comprised the remaining 20%. For each testing set, we only retained HM27 data 
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that contain a subset of HM450 probes, and masked methylation values of other HM450-
specific probes. For the training set, we used methylation measurements on probes shared 
between the two arrays as predictors to impute methylation values at HM450-specific 
probes. Because most HM27 probes were measured by both HM27 and HM450, the 
predictors used in our model can be methylation levels for these shared probes measured 
from either array. Note that our prediction model was built under the realistic (more 
challenging) scenario where we used as predictors the measurements from HM450 array 
instead of those from HM27 array, which would require the training dataset had 
measurements from both arrays. Specifically, we fitted the functional regression model 
based on the training set, learned the relationship between methylation values of the shared 
and HM450-specific probes, and used the fitted model to impute the masked values of 
HM450 probes from the HM27 data in the testing set. Finally, we evaluated the imputation 
performance by averaging quality measures across splits.
As quality measures, we selected the mean squared error (MSE) and the squared Pearson 
correlation (R2) between the imputed and the true methylation values in the testing sets. 
Although R2 is a more intuitive measure of quality directly related to power and sample size 
in downstream analysis, we would like to note that this metric could easily be affected by a 
few outliers. Additionally, if the variance of methylation values for a specific probe is small, 
R2 can be dramatically affected even by small imputation errors.
Simulation of Association Study
To assess the potential improvement of statistical power when using well-imputed 
methylation values for epigenetic association studies, we performed several simulated 
association studies for continuous and binary traits. Specifically, we randomly selected 100 
HM450 probes with imputation R2 between 0.1 and 0.3 based on our functional model, and 
simulated a dataset with 180 samples for each probe. In the continuous trait setting, for each 
probe, a trait value  was simulated from the methylation level of this probe according to 
the linear model  for sample i, where  is true methylation β value, the effect 
size c ∈ {0, 0.1, 0.2, …, 0.9, 1.0}, and , where  is the sample standard 
deviation of . In the binary trait setting, we first calculated , 
and simulated  from Bernoulli( ), where β̄* is the mean value of , and the effect size c 
∈ {0, 0.5, 1.0, …, 4.5, 5.0}.
We repeated the simulation 2000 times. For each simulated dataset, we performed 
association tests (linear regression for the continuous trait, and logistic regression for the 
binary trait) based on the true methylation values, as well as imputed values from the simple 
linear model and our proposed penalized functional model. The empirical power of each 
method was calculated as the proportion of observed P values that fall below the significance 
threshold, α = 0.05. Finally, we evaluated the empirical power for each effect size c by 
averaging results across 100 probes.
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Evaluation of Imputation Quality
Most probes showed nearly constant methylation levels in populations, making imputation 
trivial for them. We therefore focused on probes showing large variations and chose the top 
20,000 such probes to evaluate the imputation quality. The time complexity of our method 
increases linearly with the number of target probes. However, since the imputation for each 
target probe is independent, we can accelerate it by running imputation in parallel. In the 
fivefold cross-validation experiment, 14 samples used for normalization were removed at 
first. Among the remaining 180, 144 individuals were chosen at random as the training set 
and 36 as the testing set within each split. The empirical cumulative distribution of 
imputation MSE and R2 are shown in Figure 1. The baseline method we used is the “tag” 
approach, where for each target probe, we calculated the Euclidean distance between the 
target probe and local probes, chose the local probe with the smallest distance as the tag 
probe, and directly copied its methylation values as imputed values for the target probe. We 
also compared the two models with and without functional predictors and found that 
incorporating functional predictors lead to significantly improved imputation MSE and R2 
(P < 2.2 × 10−16 for both metrics, paired Wilcoxon test). Table 1 summarizes some basic 
statistics. As expected, the “tag” method performs worst and we have therefore focused in 
subsequent text only the two models with and without functional predictors.
We used the target probe cg00288598 as an example to illustrate how the functional 
predictors improve the imputation quality. As shown in Figure 2A, the selected local probes 
showed much smaller variation than the target probe, leading to an underfitted linear 
regression model and thus low imputation quality. In contrast, the methylation profile of the 
target probe is strongly associated with the distribution of methylation levels from all HM27 
probes in its assigned North Shelf group, as indicated in Figure 2B. Therefore, after the 
functional predictors are added, the model can utilize the information from these nonlocal 
probes, including probes on different chromosomes, to alleviate the underfitting problem.
Performance of Quality Metrics
Because not all target probes can be imputed with the same level of accuracy, we tried to use 
the under-dispersion measure described in the Methods section to filter out inaccurate 
imputation results. We examined the relationship between imputation MSE/R2 and the 
under-dispersion measure. We observed a negative correlation between the imputation MSE 
and this quality measure (Fig. 3A, Pearson correlation coefficient, R = −0.65), and a positive 
correlation between imputation R2 and the measure (Fig. 3B, Pearson correlation coefficient, 
R = 0.93). Therefore, when performing imputation, we can calculate the under-dispersion 
measure and use it to filter out low-quality imputation results. Figure 3 indicates that by 
choosing an appropriate threshold, we can remove most probes imputed with low-quality 
while simultaneously retaining nearly all probes imputed with high-quality. Based on our 
results, we suggest a threshold of 0.8 for the under-dispersion measure, which removes all 
badly imputed probes (defined as true R2 < 0.2) at the cost of 1.24% well-imputed probes 
(true R2 > 0.8). Table 2 shows the number of probes passing post-imputation quality filter at 
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varying thresholds of the under-dispersion measure and we see that our penalized functional 
model results in up to 86.0% more probes that can be used for further analysis.
Power Gain in Association Study
It is not surprising to find relatively little difference in the performance of the two models at 
the two ends of the distribution (Fig. 1A and B) because of probes that are either trivial or 
impossible to impute. Therefore in our work, we focus on the ~34% probes with imputation 
R2 between 0.1 and 0.3, where our model demonstrates advantages over simpler models. As 
shown in Figure 4, using imputed values from the penalized functional model for association 
tests is consistently more powerful than using values from the simple linear model, while the 
type I error rate (when c = 0) was still under proper control. These results suggest that even 
using probes with moderate imputation quality can substantially improve the statistical 
power of association test while maintaining the desired type I error rate.
Discussion
In summary, we propose a penalized functional regression framework for across-platform 
imputation of methylation probes. Although a number of methods exist for predicting 
methylation levels at single CpG resolution, none of these directly apply to the across-
platform imputation that we consider in this work. Moreover, we model information from 
nonlocal probes and have found such information considerably increase imputation 
performance. Our real data analysis demonstrates that by incorporating functional predictors 
from these nonlocal probes, our model can produce accurate imputation results when the 
reference panel (training set) and target panel (testing set) characterize the same tissue under 
similar conditions.
Because DNA methylation profiles are highly tissue and condition specific [Laurent et al., 
2010; Lister et al., 2009; Varley et al., 2013], our method will not work well if the two 
datasets are from different tissues or very different conditions. Recent studies suggest some 
statistical models to predict methylation profile in target tissue from a surrogate tissue [Ma 
et al., 2014], which might be helpful in this case. Moreover, other systematic errors such as 
batch effect may also harm imputation quality. Therefore, we suggest using techniques such 
as principal component analysis to check for obvious discrepancies between reference and 
target panels before applying our method.
In various settings, a different way to construct predictors may further improve the 
performance of our model. For example, nonlocal probes can be categorized based on other 
properties, such as their relative location to a gene [Bibikova et al., 2011]. Another possible 
approach to select nonlocal probes is to choose HM27 probes highly correlated with the 
target probe (see Supplementary Methods). Supplementary Figure S1 shows that this 
approach can lead to better imputation performance, but the computational cost will be much 
higher. We can also explore other approaches to select local covariates, such as using a 
different number of probes, or choosing the local covariates as the 10 local probes that have 
the highest correlation with the target probe.
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Because most CpG sites display stable DNA methylation levels, imputation error is low on 
average (the median imputation root MSE for beta values of all probes is ~0.05). 
Dichotomizing at beta value of 0.5 following Zhang et al. [2015], our prediction accuracy is 
94.9%, largely consistent with their reported 92% prediction accuracy. However, researchers 
may consider dynamic CpG sites to be of more interest, as these sites often colocalize with 
key regulators, such as enhancers and transcription factor binding sites [Ziller et al., 2013]. 
Therefore, we calculated quality metrics for individual probes, facilitating the evaluation of 
imputation quality for each probe and removing probes with low imputation quality for 
downstream analysis.
For probes showing a large variation of methylation levels, we notice that even after 
incorporating functional predictors, the imputation quality is still low for a significant 
portion of these probes. Possible reasons are the following: first, the DNA methylation 
profile alone does not provide sufficient information for accurate imputation. We may need 
to incorporate other information to improve imputation quality, such as local DNA context 
and the binding profile of regulatory proteins [Bhasin et al., 2005; Bock et al., 2006; Zheng 
et al., 2013], although this requires additional data sources in the same or similar tissue type 
that are rarely available. Second, HM27 has a much lower resolution than HM450. In 
addition, a large proportion of HM27 probes showed nearly constant methylation levels 
across samples. As such, an extreme case is that if the target HM450 probe is not correlated 
with any HM27 probes, the model will be underfitted with the predicted methylation levels 
for all samples close to the average, thus leading to smaller variance than expected, similar 
to under-dispersion observed with imputed SNP data [Li et al., 2009]. We expect to observe 
better performance if we impute from a denser microarray. For example, researchers are now 
replacing the HM450 array with the Illumina EPIC 850K array. We anticipate that 
imputation from 450K probes to 850K probes will exhibit a much better quality. Third, our 
normalization procedure does not fully eliminate the inconsistency of measurements 
between HM27 and HM450, which also affects the performance of our model. Here, we 
assumed only HM450 data are available for the training dataset, which is a more realistic 
setting. However, if the training set contains both HM27 and HM450 data in a real case, we 
can treat HM450 data as response and use HM27 data to construct predictors. Thus, 
predictors from both training and testing set are constructed from HM27 data and the 
inconsistency between HM27 and HM450 is automatically learned by the model. In this 
case, our model will show higher imputation accuracy.
Because a considerable proportion of CpG probes on HM450 overlap with SNPs (hereafter 
referred to as SNP-probes), we also examined whether imputation quality for these SNP-
probes differs from that for non-SNP probes. Our annotation [Barfield et al., 2014] includes 
98,741 CpGs that have an SNP somewhere underneath the 50 bp probe, among which 
62,777 are QC+ HM450-specific sites. We found that the SNP-probes are slightly less 
varying than the non-SNP probes (e.g., median variance of β values is 0.00310 and 0.00356, 
respectively; Table 3). Analogous to rarer variants in SNP imputation [Duan et al., 2013; Li 
et al., 2009; Liu et al., 2012; Pistis et al., 2015], it is not surprising to find that these SNP-
probes appear slightly easier to impute when measured using MSE (e.g., median MSE is 
0.00236 and 0.00263, respectively), but actually slightly more challenging to impute when 
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measured using the more honest information content R2 metric (median R2 is 0.162 and 
0.182, respectively).
The focus of the present work is on imputation per se rather than association analysis. After 
accurate imputation, we can combine data from multiple platforms to obtain methylation 
levels of more CpG sites for downstream analysis such as detecting methylation quantitative 
trait loci or EWAS [Heyn and Esteller, 2012; Rakyan et al., 2011]. Such analysis can take 
imputation uncertainty into account similarly as for imputed SNPs [Huang et al., 2014]. In 
this work, we evaluated the statistical power under the mostly commonly observed change in 
mean values, however, other forms of changes have been observed. For example, several 
studies [Gervin et al., 2011; Hansen et al., 2011] reported differences in the variation (in 
addition to the mean) of methylation values between cancer and healthy groups. Our 
simulation studies (Supplementary Methods S2) show a power improvement even using the 
standard logistic regression to test the mean difference under such variation differences. 
Regardless of the epigenetic architecture of the phenotype, we expect our imputation 
method, by allowing in higher resolution and more powerful exploration of the epigenome, 
will lead to rapid advances in understanding the functional role of normal DNA methylation 
and the impact of its aberration. Our method is implemented in R and freely available at 
https://github.com/Leonardo0628/pfr.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Empirical cumulative density function of (A) imputation MSE and (B) imputation R2 for 
probes showing large variations in the AML dataset.
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(A) Methylation profiles of a North Shelf probe cg00288598 (left) and 10 selected local 
probes (middle). (B) The individual-specific density plot of methylation values from all 
HM27 probes in North Shelf regions. Each line represents one individual and is colored 
based on the methylation level of the cg00288598 probe.
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Scatter plot of under-dispersion measure and (A) imputation MSE and (B) imputation R2.
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Empirical power of simulated association tests for (A) continuous trait and (B) binary trait 
across a spectrum of effect size c.
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Table 2
Number of probes passing post-imputation quality filter
Under-dispersion measure threshold 0.6 0.7 0.8 0.9
Among top 20,000 probes
Covariates only 2,113 1,592 1,174 681
Covariates + functional predictor 2,677 1,691 1,226 719
Improvement 26.7% 6.2% 4.4% 5.6%
Among all probes
Covariates only 14,479 8,796 5,123 2,417
Covariates + functional predictor 26,924 13,117 6,526 2,684
Improvement 86.0% 49.1% 27.4% 11.1%


















































































































































Genet Epidemiol. Author manuscript; available in PMC 2016 May 10.
